Category Archives: Events

Latest From Events

2013 BIO Convention in China Facilitates East-West Partnering in Biotech

biochina-flag-btn

Now in its third year, the BIO Convention in China will be held November 11-13, 2013 in Beijing, China. A sister event to the BIO International Convention, BIO China will bring together executives from biotechnology, pharmaceutical companies and investment firms from North America, Europe and Asia to meet and explore business opportunities in China, where the Rx market is poised to grow to $315 billion in 2020. For Western companies and investors looking to capitalize Read More >

Events  |  Leave a comment  |  Email This Post
Tags: , ,

12th Annual BIO Investor Forum Presenting Companies Announced

San Francisco skyline

Looking to lose a few pounds? Don’t want to diet or exercise? You’re not alone: fully one-third of Americans are obese, and many companies are trying to discover the first blockbuster diet drug and make a dent in the obesity epidemic. We’ll hear from one of those companies next month at the 12th Annual BIO Investor Forum, taking place October 8-9th in San Francisco. Cambridge-based Zafgen is hoping to bring to market their first-in-class obesity Read More >

Events  |  Leave a comment  |  Email This Post
Tags: , , , ,

Call For Sessions – Speak Now. The Industry is Listening.

BIO_SESSIONS-homepage_115x76

BIO is seeking to bring the most innovative thinkers in biotechnology together at the BIO International Convention, June 23-26th, 2014, in San Diego, CA. Speaking at the BIO International Convention gives you access to biotech thought leaders from over 4,000 companies in 65 countries. BIO is seeking speakers who are forward leaning, engaging and who drive meaningful discussion about what’s on the forefront of the industry. Education enhancements in 2014 include: streamlined session tracks organized Read More >

Events  |  Leave a comment  |  Email This Post
Tags: , , , , ,

BIO Investor Forum Company Snapshot: NovelMed Therapeutics

NovelMed

NovelMed Therapeutics will be presenting at the upcoming BIO Investor Forum in October in San Francisco. Read below to learn more about their antibodies portfolio, what differentiates their company for the competition, and other interesting facts about the company. Company Snapshot What is your company’s lead product or technology? NovelMed has developed a portfolio of fully humanized monoclonal antibodies that selectively target only the disease-associated Complement System. As such, NovelMed’s antibodies are active against multiple Read More >

The One-on-One Compass  |  Leave a comment  |  Email This Post
Tags: , , , ,

BIO Investor Forum Company Snapshot: MAX BioPharma

maxbiopharma

Earlier this week, we featured a presenting company for our upcoming BIO Investor Forum event in San Francisco in our ‘company snapshot‘ feature. For our next post, we spoke to MAX BioPharma, who will be giving a presentation in our Discovery Company presentation track, which features companies in their Seed or Series A financing rounds, with under 25 million raised to date. Read on to learn more about this Discovery Company.   Company Snapshot What Read More >

The One-on-One Compass  |  Leave a comment  |  Email This Post
Tags: , , , , ,